Variations in illumination, closed wall transparency and/or extramaze space influence both baseline anxiety and response to diazepam in the rat elevated plus-maze

Behavioural Brain Research

Volumn 203, Issue 1, 2009, Pages 35-42

  Violle, Nicolas ^a   Balandras, Frédérique ^a   Le Roux, Yves ^a   Desor, Didier ^a   Schroeder, Henri ^a  

^a UNIVERSITÉ DE LORRAINE   (France)

Author keywords

Baseline anxiety level; Closed wall type; Diazepam; Elevated plus maze; Extramaze space size; Illumination; Rat; Test sensitivity

Indexed keywords

DIAZEPAM;

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; AVOIDANCE BEHAVIOR; CONTROLLED STUDY; DRUG RESPONSE; EXPLORATORY BEHAVIOR; ILLUMINATION; MALE; MAZE TEST; MOVEMENT PERCEPTION; NONHUMAN; PRIORITY JOURNAL; RAT; RED LIGHT; SENSITIVITY ANALYSIS; SPATIAL DISCRIMINATION; VALIDATION PROCESS;

ANALYSIS OF VARIANCE; ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; BEHAVIOR, ANIMAL; CHOICE BEHAVIOR; DIAZEPAM; ENVIRONMENT; FACTOR ANALYSIS, STATISTICAL; LIGHTING; MALE; MAZE LEARNING; MOTOR ACTIVITY; RANDOM ALLOCATION; RATS; RATS, WISTAR;

EID: 67349278160     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2009.04.015     Document Type: Article

References (49)

1. Anseloni V.Z., and Brandao M.L. Ethnopharmacological analysis of behaviour of rats using variations of the elevated plus-maze. Behav Pharmacol 8 (1997) 533-540
2. Anseloni V.Z., Motta V., Lima G., and Brandao M.L. Behavioural and pharmacological validation of the elevated plus-maze constructed with transparent walls. Braz J Med Biol Res 28 (1995) 597-601
3. Belzung C., and Griebel G. Measuring normal and pathological anxiety-like behaviour in mice: a review. Behav Brain Res 125 (2001) 141-149
4. Benaroya-Milshtein N., Hollander N., Apter A., Kukulansky T., Raz N., Wilf A., et al. Environmental enrichment in mice decreases anxiety, attenuates stress responses and enhances natural killer cell activity. Eur J Neurosci 20 (2004) 1341-1347
5. Bertoglio L.J., and Carobrez A.P. Behavioral profile of rats submitted to session 1-session 2 in the elevated plus-maze during diurnal/nocturnal phases and under different illumination conditions. Behav Brain Res 132 (2002) 135-143
6. Bertoglio L.J., and Carobrez A.P. Previous maze experience required to increase open arms avoidance in rats submitted to the elevated plus-maze model of anxiety. Behav Brain Res 108 (2000) 197-203
7. Bouwknech J.A., and Paylor R. Pitfalls in the interpretation of genetic and pharmacological effects on anxiety-like behaviour in rodents. Behav Pharmacol 19 (2008) 385-402
8. Cardenas F., Lamprea M.R., and Morato S. Vibrissal sense is not the main sensory modality in rat exploratory behavior in the elevated plus-maze. Behav Brain Res 122 (2001) 169-174
9. Carobrez A.P., and Bertoglio L.J. Ethological and temporal analyses of anxiety-like behavior: the elevated plus-maze model 20 years on. Neurosci Biobehav Rev 29 (2005) 1193-1205
10. Carr M.N., Bekku N., and Yoshimura H. Identification of anxiolytic ingredients in ginseng root using the elevated plus-maze test in mice. Eur J Pharmacol 531 (2006) 160-165
11. Chen W.I., Mi X.J., Wang R., Wang W.J., Kong W.X., Zhang Y.J., et al. Behavioral effects of sinomenine in murine models of anxiety. Life Sci 78 (2005) 232-238
12. Cole J.C., and Rodgers R.J. Ethological evaluation of the effects of acute and chronic buspirone treatment in the murine elevated plus-maze test: comparison with haloperidol. Psychopharmacology 114 (1993) 288-296
13. Cosquer B., Galani R., Kuster N., and Cassel J.C. Whole-body exposure to 2.45 GHz electromagnetic fields does not alter anxiety responses in rats: a plus-maze study including test validation. Behav Brain Res 156 (2005) 65-74
14. Cruz A.P., Frei F., and Graeff F.G. Ethopharmacological analysis of rat behavior on the elevated plus-maze. Pharmacol Biochem Behav 49 (1994) 171-176
15. Eilam D., Dank M., and Maurer R. Voles scale locomotion to the size of the open-field by adjusting the distance between stops: a possible link to path integration. Behav Brain Res 141 (2003) 73-81
16. Eilam D. Open field behaviour withstands drastic changes in arena size. Behav Brain Res 142 (2003) 53-62
17. File S.E., Kenny P.J., and Cheeta S. The role of the dorsal hippocampal serotonergic and cholinergic systems in the modulation of anxiety. Pharmacol Biochem Behav 66 (2000) 65-72
18. Finley Jr. R.B. Observation of nocturnal animals by red light. J Mammal 40 (1959) 591-594
19. Garcia A.M.B., Cardenas F.P., and Morato S. Effect of different illumination levels on rat behavior in the elevated plus-maze. Physiol Behav 85 (2005) 265-270
20. Griebel G., Rodgers R.J., Perrault G., and Sanger D.J. Risk assessment behaviour: Evaluation of utility in the study of 5-HT-related drugs in the rat elevated plus-maze test. Pharmacol Biochem Behav 57 (1997) 817-827
21. Gries D.A., Condouris G.A., Shey Z., and Houpt M. Anxiolytic-like action in mice treated with nitrous oxide and oral triazolam or diazepam. Life Sci 76 (2005) 1667-1674
22. Grova N., Schroeder H., Farinelle S., Prodhomme E., Valley A., and Muller C. Sub-acute administration of benzo[a]pyrene (B[a]P) reduces anxiety-related behaviour in adult mice and modulates regional expression of N-methyl-d-aspartate (NMDA) receptors genes in relevant brain regions. Chemosphere 73 (2008) S295-302
23. Grundmann O., Nakajima J.I., Seo S., and Butterweck V. Anti-anxiety effects of Apocynum venetum L. in the elevated plus maze test. J Ethnopharmacol 110 (2007) 406-411
24. Hagenbuch N., Feldon J., and Yee B.K. The use of the elevated plus-maze test with opaque or transparent walls in the detection of mouse strain differences and the anxiolytic effects of diazepam. Behav Pharmacol 16 (2005) S106-107
25. Handley S.L., and Mithani S. Effects of alpha-adrenoreceptor agonists and antagonists in a maze-exploration model of 'fear'-motivated behaviour. Naunyn Schmiedebergs Arch Pharmacol 327 (1984) 1-5
26. Hendrie C.A., Eilam D., and Weiss S.M. Effects of diazepam and buspirone on the behaviour of wild voles (microtus socialis) in two models of anxiety. Pharmacol Biochem Behav 58 (1997) 573-576
27. Iwata E., Kikusui T., Takeuchi T., and Mori Y. Fostering and environmental enrichment ameliorate anxious behavior induced by early weaning in Balb/c mice. Physiol Behav 91 (2007) 318-324
28. Jacobs G.H., Fenwick J.A., and Williams G.A. Cone-based vision of rats for ultraviolet and visible lights. J Exp Biol 204 (2001) 2439-2446
29. Jacobs G.H., Neltz J., and Deegan J.N. Retinal receptors in rodents maximally sensitive to ultraviolet light. Nature 353 (1991) 655-656
30. Jones N., and King S.M. Influence of circadian phase and test illumination on preclinical models of anxiety. Physiol Behav 72 (2001) 99-106
31. Kelliher P., Connor T.J., Harkin A., Sanchez C., Kelly J.P., and Leonard B.E. Varying responses to the rat forced-swim test under diurnal and nocturnal conditions. Physiol Behav 69 (2000) 531-539
32. Martinez J.C., Cardenas F., Lamprea M., and Morato S. The role of vision and proprioception in the aversion of rats to the open arms of an elevated plus-maze. Behav Processes 60 (2002) 15-26
33. Ohl F. Testing for anxiety. Clin Neurosci Res 3 (2003) 233-238
34. Painsipp E., Wultsch T., Shahbazian A., Edelsbrunner M., Kreissl M.C., Schirbel A., et al. Experimental gastritis in mice enhances anxiety in a gender-related manner. Neuroscience 150 (2007) 522-536
35. Pellow S., Chopin P., File S.E., and Briley M. Validation of open/closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14 (1985) 149-167
36. Pereira L.E., Da Cunha I.C., Neto M.J., Paschoalini M.A., and Faria M.S. The gradient of luminosity between open/enclosed arms, and not the absolute level of Lux, predicts the behaviour of rats in the plus-maze. Behav Brain Res 159 (2005) 55-61
37. Prut L., and Belzung C. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol 463 (2003) 3-33
38. Ramos J.M.J. Influence of the shape of the experimental room on spatial learning in rats. Physiol Behav 70 (2002) 351-357
39. Rex A., Morgenstern E., and Fink H. Anxiolytic-like effects of Kava-Kava in the elevated plus maze test-a comparison with diazepam. Prog Neuropsychopharmacol Biol Psychiatry 26 (2002) 855-860
40. Rodgers R.J., and Dalvi A. Anxiety, defence and the elevated plus-maze. Neurosci Biobehav Rev 21 (1997) 801-810
41. Rodgers R.J., and Johnson J.T. Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety. Pharmacol Biochem Behav 52 (1995) 297-303
42. Salum C., Roque-da-Silva A.C., and Morato S. Conflict as a determinant of rat behavior in three types of elevated plus-maze. Behav Processes 63 (2003) 87-93
43. Schellinck H.M., Stanford L., and Darrah M. Repetitive acute pain in infancy increases anxiety but does not alter spatial learning ability in juvenile mice. Behav Brain Res 142 (2003) 157-165
44. Setem J., Pinheiro A.P., Motta V.A., Morato S., and Cruz A.P.M. Ethopharmacological analysis of 5-HT ligands on the rat elevated plus-maze. Pharmacol Biochem Behav 62 (1999) 515-521
45. Soeiro A.C., Gouvêa T.S., and Moreira E.G. Behavioral effects induced by subchronic exposure to Pb and their reversion are concentration and gender dependent. Hum Exp Toxicol 26 (2007) 733-739
46. Treit D., and Fundytus M. Thigmotaxis as a test for anxiolytic activity in rats. Pharmacol Biochem Behav 31 (1988) 959-962
47. Treit D., Menard J., and Royan C. Anxiogenic stimuli in the elevated plus-maze. Pharmacol Biochem Behav 44 (1993) 463-469
48. Vergura R., Balboni G., Spagnolo B., Gavioli E., Lambert D.G., McDonald J., et al. Anxiolytic- and antidepressant-like activities of H-Dmt-Tic-NH-CH(CH(2)-COOH)-Bid (UFP-512), a novel selective delta opioid receptor agonist. Peptides 29 (2008) 93-103
49. Violle N., Messaoudi M., Lefranc-Millot C., Desor D., Nejdi A., Demagny B., et al. Ethological comparison of the effects of a bovine alphas1-casein tryptic hydrolysate and diazepam on the behaviour of rats in two models of anxiety. Pharmacol Biochem Behav 84 (2006) 517-523